Spinal Morphine in Robotic Assisted Radical Prostatectomy

Spinal Morphine in Robotic Assisted Radical Prostatectomy - SALMON-RARP

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON43716

Enrollment

160

Registered

2016-05-23

Start date

2016-09-26

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain after prostatectomy woundpain

Interventions

Spinal injection of bupivacaine/morphine.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults (>18 years), scheduled for RARP

Exclusion criteria

Exclusion criteria: Age under 18 years old, Renal Insufficiency (MRDR

Design outcomes

Primary

Measure	Time frame
QoR-15-scale at day 1 and day 7-10.	—

Secondary

Measure	Time frame
Secundary goals are to decrease the use of systemic opiates (in mg of morfine). Less bladderspasms and pain (both on a NRS-scale (0-10) Reduce the side-effects op opiates (nausea, vomiting, pruritus, sedation (NRS 0-10) Increase the patient-satisfaction (NRS 0-10), mobility (NRS 0-10) and surgical workspace (NRS 0-10).	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)